Results 191 to 200 of about 1,468,312 (258)

Anti‐CD3 × anti‐GD2 bispecific antibody redirects T‐cell cytolytic activity to neuroblastoma targets [PDF]

, 2012
Maxim Yankelevich, Sri Vidya Kondadasula, Archana Thakur, Steven Buck, Nai‐Kong V. Cheung, Lawrence G. Lum   +5 more
openalex   +1 more source

Bone Formation and the Wnt Signaling Pathway. [PDF]

, 2016
Baron, R., Gori, F., Superti-Furga, A.
core   +1 more source

Bispecific Antibodies, Nanobodies and Extracellular Vesicles: Present and Future to Cancer Target Therapy. [PDF]

Biomolecules
Lizama-Muñoz A, Plaza-Diaz J.
europepmc   +1 more source

The Current State of Bispecific Antibodies and T-Cell Directed Therapy in NHL. [PDF]

Cancers (Basel)
Kordic A, Phillips TJ, Weiss J.
europepmc   +1 more source

Chimeric antigen receptor T-cell therapy remains effective after exposure to bispecific antibodies. Comment to "Sequencing of cellular therapy and bispecific antibodies for the management of diffuse large B-cell lymphoma". [PDF]

Haematologica
Crochet G, Houot R.
europepmc   +1 more source

Measurable Residual Disease Testing During Treatment with Bispecific Antibodies for Lymphoma. [PDF]

Cancers (Basel)
Jean-Louis G, Cherng HJ.
europepmc   +1 more source

Predictive factors and nomogram for the risk of cytokine release syndrome with anti-CD3 × CD20 bispecific antibodies for Chinese patients. [PDF]

Cancer Immunol Immunother
Sun P, Chen C, Zhao BT, Zhang BY, Yang H, Wang Y, Xu F, Huang KM, Liu YT, Ouyang MS, Huang JJ, Liu PP, Guo Y, Li ZM.   +13 more
europepmc   +1 more source

QSP modeling of loncastuximab tesirine with T-cell-dependent bispecific antibodies guides dose-regimen strategy. [PDF]

NPJ Syst Biol Appl
Li Y, Wilkins AK, Davis J, Knab T, Toukam M, Boni JP, Kirouac DC.   +6 more
europepmc   +1 more source

Bispecific Antibodies and CAR T in Multiple Myeloma: Appropriate Selection of Patients and Sequencing. [PDF]

Mediterr J Hematol Infect Dis
Puppi M, Sacchetti I, Mancuso K, Tacchetti P, Pantani L, Rizzello I, Iezza M, Talarico M, Manzato E, Masci S, Restuccia R, Barbato S, Armuzzi S, Taurisano B, Vigliotta I, Zamagni E.   +15 more
europepmc   +1 more source

Targeted mRNA delivery with bispecific antibodies that tether LNPs to cell surface markers. [PDF]

Mol Ther Nucleic Acids
Dietmair B, Humphries J, Mercer TR, Thurecht KJ, Howard CB, Cheetham SW.   +5 more
europepmc   +1 more source